Lou Yu Yan
Director/Board Member bij ESLITE SPECTRUM CORPORATION
Profiel
Lou Yu Yan currently works at Qisda Corp., as Independent Director from 2020, Sinyi Realty, Inc., as Independent Director from 2017, ANZ Banking Corp., as Independent Director, and The Eslite Spectrum Corp., as Independent Director.
Mr. Yan also formerly worked at Chunghwa Telecom Co., Ltd., as Independent Director and Crown Bioscience International, as Independent Director.
Mr. Yan received his graduate degree from National Chengchi University.
Actieve functies van Lou Yu Yan
| Bedrijven | Functie | Begin |
|---|---|---|
| ESLITE SPECTRUM CORPORATION | Director/Board Member | - |
| SINYI REALTY INC. | Director/Board Member | 26-05-2017 |
| QISDA CORPORATION | Director/Board Member | 19-06-2020 |
ANZ Banking Corp.
 ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Director/Board Member | - |
Eerdere bekende functies van Lou Yu Yan
| Bedrijven | Functie | Einde |
|---|---|---|
| CHUNGHWA TELECOM CO., LTD. | Director/Board Member | - |
| CROWN BIOSCIENCE INTERNATIONAL | Director/Board Member | - |
Opleiding van Lou Yu Yan
| National Chengchi University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| CHUNGHWA TELECOM CO., LTD. | Communications |
| QISDA CORPORATION | Electronic Technology |
| SINYI REALTY INC. | Finance |
| ESLITE SPECTRUM CORPORATION | Finance |
| Bedrijven in privébezit | 2 |
|---|---|
ANZ Banking Corp.
ANZ Banking Corp. Regional BanksFinance ANZ Banking Corp. provides commercial banking services. The company is headquartered in Northcote, Australia. | Finance |
Crown Bioscience International
 Crown Bioscience International BiotechnologyHealth Technology Crown Bioscience International develops drug for Oncology and Metabolic Diseases. Its products include Antibodies for in vivo & in vitro studies, Tissues for CVMD research and therapeutic R&D, Recombinant cell lines, Tumor samples for oncology research & drug development. The company founded on October 22, 2013 and is headquartered in Taipei, Taiwan. | Health Technology |
